FindTrial
Sign In

Rosuvastatin and Ezetimibe

DRUG5 trials

Sponsors

Instituto De Investigacion Marques De Valdecilla, NVP Healthcare, Hanmi Pharmaceutical Company Limited, Korea University Anam Hospital, Kirby Institute

Conditions

Atheroscleroses, CoronaryCHRONIC INFLAMMATORY RHEUMATIC DISEASE: rheumatoid arthritis or psoriatic arthritis or axial spondyloarthritis or systemic lupus erythematosusDyslipidemiaDyslipidemiasHIV InfectionsHypertensionWeight Gain

Phase 1

Compare the Pharmacokinetics of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe
CompletedNCT02029625
NVP HealthcareDyslipidemia
Start: 2014-02-28End: 2014-03-31Updated: 2016-03-25

Phase 3

A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia
CompletedNCT04074551
Hanmi Pharmaceutical Company LimitedDyslipidemias, Hypertension
Start: 2019-07-16End: 2020-03-17Updated: 2020-11-30
Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART)
Active, not recruitingNCT06317051
Kirby InstituteHIV Infections, Weight Gain
Start: 2024-12-16End: 2027-12-01Target: 300Updated: 2026-07-22

Phase 4

Effects of Statin for Elderly Patients With Atherosclerotic Cardiovascular Disease
CompletedNCT04826354
Korea University Anam HospitalAtheroscleroses, Coronary
Start: 2021-08-11End: 2023-06-28Updated: 2023-08-08
Randomized clinical trial to assess the efficacy and safety of a strategy for primary prevention of cardiovascular disease in patients with inflammatory rheumatic diseases based on the use of carotid ultrasound.
Not yet recruitingCTIS2025-521086-28-00
Instituto De Investigacion Marques De ValdecillaCHRONIC INFLAMMATORY RHEUMATIC DISEASE: rheumatoid arthritis or psoriatic arthritis or axial spondyloarthritis or systemic lupus erythematosus
Target: 1250Updated: 2025-10-03

Related Papers

Metabolic and Safety Outcomes of Statin-Ezetimibe Versus High-Intensity Statin in Older Patients.
2026-07-03
Optimizing metabolic management on integrase-based ART (OPTIMAR): study protocol for a 2 × 2 factorial, randomised, double-blind placebo-controlled trial to compare the addition of dapagliflozin versus placebo, and rosuvastatin plus ezetimibe versus pitavastatin, in people with HIV on integrase strand transfer inhibitor-based antiretroviral therapy with elevated metabolic risk.
2026-04-29
A Randomized, Multicenter, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Quadruple Combination of Amlodipine, Losartan, Rosuvastatin, and Ezetimibe in Patients with Concomitant Essential Hypertension and Dyslipidemia
American Journal of Cardiovascular Drugs2023-07-017 citations
Pharmacokinetics and bioequivalence of a rosuvastatin/ezetimibe fixed-dose combination tablet versus single agents in healthy male subjects
.
2018-01-019 citations